Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome | Zendy

Gautham Appanna | Zendy; Tom Pembroke | Zendy; Kelly L. Miners | Zendy; David A. Price | Zendy; Awen Gallimore | Zendy; Kristin Ladell | Zendy; Andrew Godkin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome

Author(s) -

Gautham Appanna,

Tom Pembroke,

Kelly L. Miners,

David A. Price,

Awen Gallimore,

Kristin Ladell,

Andrew Godkin

Publication year - 2019

Publication title -

qjm

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.427

H-Index - 118

eISSN - 1460-2725

pISSN - 1460-2393

DOI - 10.1093/qjmed/hcz161

Subject(s) - rituximab , refractory (planetary science) , medicine , immunology , antibody , biology , astrobiology

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome G.D. Appanna , T.P.I. Pembroke , K.L. Miners, D.A. Price , A.M. Gallimore, K. Ladell 1 and A.J. Godkin From the Division of Infection and Immunity, Cardiff University School of Medicine and Department of Gastroenterology and Hepatology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research